Total Payments
$1,190
2023 Payments
$112.83
Companies
19
Transactions
66
Medicare Patients
1,205
Medicare Billing
$153,479
Payment Breakdown by Category
Food & Beverage$1,190 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,190 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $196.32 | 11 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $172.64 | 11 | $0 (2023) |
| Allergan, Inc. | $150.98 | 10 | $0 (2020) |
| RedHill Biopharma Inc. | $113.17 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $67.72 | 4 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $63.98 | 4 | $0 (2018) |
| Boston Scientific Corporation | $57.81 | 3 | $0 (2023) |
| ABBVIE INC. | $49.63 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $48.45 | 2 | $0 (2018) |
| PFIZER INC. | $44.66 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $112.83 | 6 | E.R. Squibb & Sons, L.L.C. ($29.51) |
| 2022 | $108.42 | 6 | E.R. Squibb & Sons, L.L.C. ($49.15) |
| 2021 | $200.29 | 7 | RedHill Biopharma Inc. ($113.17) |
| 2020 | $34.23 | 2 | Allergan, Inc. ($34.23) |
| 2019 | $119.44 | 8 | Merck Sharp & Dohme Corporation ($53.64) |
| 2018 | $238.88 | 14 | Allergan Inc. ($81.37) |
| 2017 | $375.67 | 23 | Merck Sharp & Dohme Corporation ($97.21) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: Cardiovascular | ||||||
| 07/12/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/01/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Rare Disease | ||||||
| 05/03/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Cardiovascular | ||||||
| 04/27/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Diabetes | ||||||
| 11/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| Category: Cardiovascular | ||||||
| 09/02/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Cardiovascular | ||||||
| 08/05/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: WATCHMAN_IC | ||||||
| 07/08/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: Cardiovascular | ||||||
| 07/06/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/08/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: WATCHMAN_IC | ||||||
| 11/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $113.17 | General |
| Category: Antibiotic | ||||||
| 09/24/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/18/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/05/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/21/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: Cardiovascular | ||||||
| 05/20/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/29/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/20/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/22/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/08/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 260 | 507 | $63,492 | $35,693 |
| 2022 | 4 | 228 | 485 | $41,920 | $30,024 |
| 2021 | 4 | 314 | 639 | $60,336 | $42,987 |
| 2020 | 7 | 403 | 715 | $62,314 | $44,776 |
Total Patients
1,205
Total Services
2,346
Medicare Billing
$153,479
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 327 | $35,457 | $19,756 | 55.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 80 | $13,322 | $7,220 | 54.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 65 | 66 | $9,671 | $5,686 | 58.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $2,766 | $1,732 | 62.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 21 | 21 | $2,277 | $1,299 | 57.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 113 | 330 | $25,036 | $18,024 | 72.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 72 | $8,072 | $5,628 | 69.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 65 | 69 | $7,753 | $5,594 | 72.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 14 | $1,060 | $777.56 | 73.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 124 | 323 | $24,924 | $17,999 | 72.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 83 | 204 | $23,146 | $16,481 | 71.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 84 | 89 | $10,266 | $7,303 | 71.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 23 | 23 | $2,001 | $1,203 | 60.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 164 | 403 | $31,759 | $23,108 | 72.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 49 | 89 | $10,352 | $7,358 | 71.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 69 | 72 | $8,481 | $6,108 | 72.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 58 | 58 | $4,776 | $3,342 | 70.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 37 | 67 | $2,824 | $2,094 | 74.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $3,031 | $2,073 | 68.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 13 | 13 | $1,091 | $693.04 | 63.5% |
About Dr. Pingali Chandra Mohan, M.D
Dr. Pingali Chandra Mohan, M.D is a Internal Medicine healthcare provider based in Findlay, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1558509109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pingali Chandra Mohan, M.D has received a total of $1,190 in payments from pharmaceutical and medical device companies, with $112.83 received in 2023. These payments were reported across 66 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,190).
As a Medicare-enrolled provider, Chandra Mohan has provided services to 1,205 Medicare beneficiaries, totaling 2,346 services with total Medicare billing of $153,479. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Findlay, OH
- Active Since 02/04/2009
- Last Updated 01/19/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558509109
Products in Payments
- DIFICID (Drug) $166.29
- ELIQUIS (Drug) $113.27
- Talicia (Drug) $113.17
- AVYCAZ (Drug) $101.86
- TEFLARO (Drug) $87.77
- SAMSCA (Drug) $63.98
- CAMZYOS (Drug) $59.37
- STIOLTO (Drug) $48.97
- ENTRESTO (Drug) $48.45
- PREVNAR - 13 (Biological) $44.66
- WATCHMAN Access System (Device) $41.66
- XARELTO (Drug) $40.74
- LifeVest (Device) $37.96
- Rybelsus (Drug) $23.91
- Veltassa (Drug) $23.03
- LANTUS (Drug) $19.71
- PRADAXA (Drug) $18.75
- KYPHON Balloon Kyphoplasty (Device) $17.08
- CUBICIN RF (Drug) $16.21
- OFIRMEV (Drug) $16.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Findlay
Dr. Bruce Bouts, M.d, M.D
Internal Medicine — Payments: $8,121
Internal Medicine $8,121
Dr. Mark Fox, M.d, M.D
Internal Medicine — Payments: $3,889
Internal Medicine $3,889
Dr. Gregory Ricketts, M.d, M.D
Internal Medicine — Payments: $3,331
Internal Medicine $3,331
Dr. Lisa Knor, M.d, M.D
Internal Medicine — Payments: $1,832
Internal Medicine $1,832
Maitri Kalia-Reynolds, D.o., M.s, D.O., M.S
Internal Medicine — Payments: $1,380
Internal Medicine $1,380
Pradeep Kumaralingam, M.d, M.D
Internal Medicine — Payments: $842.01
Internal Medicine $842.01